Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC 4.0Renal Failure

Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy

  1. 1Division of Nephrology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
  2. 2Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea

Abstract

Objective: The prognostic nutritional index (PNI) reflects immunonutritional status and serves as a prognostic marker in various diseases. However, its clinical significance in IgA nephropathy (IgAN) remains poorly understood. We investigated the association between PNI and clinico-pathological severity as well as long-term kidney outcomes in IgAN.

Methods: We retrospectively analyzed 153 patients with biopsy-proven IgAN. Patients were categorized into four PNI groups (<40, 40–50 [reference], 50–55, and ≥55). The primary outcome was urine protein-to-creatinine ratio (UPCR) at biopsy; secondary outcomes were pathological severity (Oxford MEST-C and Haas classifications) and a composite kidney outcome (creatinine doubling, ≥40% eGFR decline, or dialysis initiation).

Results: In the fully adjusted models, the lowest PNI group (<40) exhibited a 3.49-fold higher UPCR (AMR 3.49; p < 0.001) and was independently associated with segmental sclerosis (S1) (OR 5.09; p=0.029) and crescents (C1/2) (OR 3.81; p=0.031). Conversely, the highest PNI group (≥55) showed lower UPCR (AMR 0.47; p<0.001), reduced risk of advanced tubular atrophy/interstitial fibrosis (T1/2) (OR 0.31; p=0.042), and lower Haas stages (OR 0.29; p=0.010). Although the association with long-term outcomes was attenuated after UPCR adjustment in the total cohort, the lowest PNI group maintained a highly significant risk among patients with non-nephrotic range proteinuria (HR 17.99; p=0.006).

Conclusion: PNI was associated with proteinuria and histological severity in IgAN and may provide additional prognostic information for long-term kidney outcomes beyond proteinuria alone, particularly in patients with non-nephrotic-range proteinuria.

Related

  1. Computed tomography-based measurements of fat quality are associated with the prognostic nutritional index in gastric cancer patients
    Ryohei Nishiguchi, Shinichi Asaka, Masano Sagawa +9
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyCrossref
  2. Clinical impact of the prognostic nutritional index at listing and immediately before surgery in lung transplantation
    Shinji Yuhara, Gouji Toyokawa, Junichi Takada +9
    Surgery TodayPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  3. Clinical Impact of Prognostic Immune and Nutritional Index on Short- and Long-term Outcomes of Older Patients with Colorectal Cancer.
    Daiki Matsubara, Miki Tanaka, Atsuhito Ando +5
    Journal of the anus, rectum and colonPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  4. HIV‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise
    Deepak V. Pathiyil, Nicola Wearne, Brendon Price +2
    HIV MedicinePeer-reviewedCC BY 4.0Full textInfectious diseasePMC
  5. Pretreatment Prognostic Nutritional Index Is Associated with Treatment Response and Survival in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Receiving CAR-T Cell Therapy
    Zhengyuan Han, Yadi Zhong, Zijian Lv +2
    NutrientsPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
BibTeX
@article{kim2026prognostic,
  title = {{Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy}},
  author = {Woogyeom Kim and Moon-il Park and Jin Hee Na and In Ho Park and Sung Rok Kim and Yu-Ji Lee},
  journal = {Renal Failure},
  year = {2026},
  month = nov,
  doi = {10.1080/0886022x.2026.2755141},
  url = {https://doi.org/10.1080/0886022x.2026.2755141},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy
AU  - Woogyeom Kim
AU  - Moon-il Park
AU  - Jin Hee Na
AU  - In Ho Park
AU  - Sung Rok Kim
AU  - Yu-Ji Lee
PY  - 2026
DA  - 2026/11/04
JO  - Renal Failure
DO  - 10.1080/0886022x.2026.2755141
UR  - https://doi.org/10.1080/0886022x.2026.2755141
AB  - Objective: The prognostic nutritional index (PNI) reflects immunonutritional status and serves as a prognostic marker in various diseases. However, its clinical significance in IgA nephropathy (IgAN) remains poorly understood. We investigated the association between PNI and clinico-pathological severity as well as long-term kidney outcomes in IgAN.  Methods: We retrospectively analyzed 153 patients with biopsy-proven IgAN. Patients were categorized into four PNI groups (<40, 40–50 [reference], 50–55, and ≥55). The primary outcome was urine protein-to-creatinine ratio (UPCR) at biopsy; secondary outcomes were pathological severity (Oxford MEST-C and Haas classifications) and a composite kidney outcome (creatinine doubling, ≥40% eGFR decline, or dialysis initiation).  Results: In the fully adjusted models, the lowest PNI group (<40) exhibited a 3.49-fold higher UPCR (AMR 3.49; p < 0.001) and was independently associated with segmental sclerosis (S1) (OR 5.09; p=0.029) and crescents (C1/2) (OR 3.81; p=0.031). Conversely, the highest PNI group (≥55) showed lower UPCR (AMR 0.47; p<0.001), reduced risk of advanced tubular atrophy/interstitial fibrosis (T1/2) (OR 0.31; p=0.042), and lower Haas stages (OR 0.29; p=0.010). Although the association with long-term outcomes was attenuated after UPCR adjustment in the total cohort, the lowest PNI group maintained a highly significant risk among patients with non-nephrotic range proteinuria (HR 17.99; p=0.006).  Conclusion: PNI was associated with proteinuria and histological severity in IgAN and may provide additional prognostic information for long-term kidney outcomes beyond proteinuria alone, particularly in patients with non-nephrotic-range proteinuria.
SN  - 0886-022X
SN  - 1525-6049
ER  -